Bipolar H.A Versus Trochanteric Antegrade Nail for Treatment of Displaced Subcapital Femoral Fractures

Displaced Subcapital Femoral Fracture Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01181037
• Other study ID #: mmc10039-2010ctil
• Secondary ID: 0392010
• Status: Recruiting
• Phase: N/A
• First received: May 2, 2010
• Last updated: March 16, 2012
• Start date: June 2010
• Est. completion date: April 2012

Study information

• Verified date: March 2012
• Source: Meir Medical Center
• Contact: yaron brin, MD
• Phone: 0545784734
• Email: yaronbrin[@]gmail.com
• Is FDA regulated: No
• Health authority: Israel: Ethics Commission
• Study type: Observational

Clinical Trial Summary

A retrospective study to compare clinical results of patients that were treated by Bipolar H.A. vs. closed reduction and internal fixation with Trochanteric Antegrade Nail for displaced femoral subcapital fracture.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: April 2012
• Est. primary completion date: April 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 40 Years to 85 Years

Eligibility

Inclusion Criteria:

• Displaced femoral subcapital fracture.

• Active patient.

• Age 40-85.

• Patient was treated by one of the two methods.

Exclusion Criteria:

• Age out of range.

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Displaced Subcapital Femoral Fracture
• Femoral Fractures
• Fractures, Bone

Locations

Country	Name	City	State
Israel	Meir Medical Center	Kfar - Saba

Sponsors (1)

Lead Sponsor	Collaborator
Meir Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	describe treatment of patients that were treated by Bipolar H.A. vs. closed reduction and internal fixation	A retrospective study will defer between groups	6month to 3 years following operation	No